Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.
Industry News
Georgia State University Plans Biocontainment Research Facility
Georgia State University is planning to construct a $35 million biocontainment research facility in Atlanta. Located on the Downtown campus, the 55,000-sf building will provide BSL-3 and BSL-4 laboratories for the study of infectious diseases and select agents. The project, which will be the first academic BSL-4 facility in the Southeast, will include open research labs, offices, and support space.
University of Tennessee Constructs Science Center
The University of Tennessee is constructing the $118 million Ken and Blaire Mossman Building in Knoxville. Designed by McCarty Holsaple McCarty and Lord Aeck Sargent, the six-story, 222,000-sf facility will accommodate programs in microbiology, psychology, nutrition, biochemistry, and cellular and molecular biology. Offering spaces for both structured and unstructured interaction, the collaborative project includes classrooms ranging from 81 to 126 seats, indoor and outdoor gathering spaces, a 228-seat auditorium, and a café.
Carleton University Opens Academic Health Science Building
Carleton University opened the CAD$52 million Academic Health Science Building in January of 2018 in Ottawa. Designed by Montgomery Sisam Architects and NXL Architects, the seven-story, 120,000-sf facility provides undergraduate teaching labs, research labs, lecture halls, offices, and study spaces to support neuroscience and health science programs. The project includes two floors of shell space to allow for future growth, as well as an animal research vivarium on the seventh floor that will open later in 2018.
Wuhan Institute of Virology Begins BSL-4 Laboratory Operations
The Wuhan Institute of Virology began operations in its BSL-4 laboratories in January of 2018. Supporting research on infectious diseases and select agents, the biocontainment facility will enable scientists to develop innovative strategies for the detection and mitigation of pathogenic threats. Construction began on the facility in 2011 with trial operations beginning in 2015.
Boehringer Ingelheim Expands Animal Vaccine Production Facilities
Boehringer Ingelheim began construction in December of 2017 on a 50,000-sf expansion of its 350,000-sf animal vaccine production facility in Athens, Ga. The completed 400,000-sf project will begin commercial operations in mid-2019. Boehringer Ingelheim will also construct a 13,000-sf addition for the manufacture of livestock animal vaccines on its 700,000-sf campus in St. Joseph, Mo.